Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.09
BDX's Cash-to-Debt is ranked lower than
93% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. BDX: 0.09 )
Ranked among companies with meaningful Cash-to-Debt only.
BDX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.23 Max: N/A
Current: 0.09
Equity-to-Asset 0.33
BDX's Equity-to-Asset is ranked lower than
82% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. BDX: 0.33 )
Ranked among companies with meaningful Equity-to-Asset only.
BDX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.47 Max: 0.63
Current: 0.33
0.25
0.63
Interest Coverage 5.01
BDX's Interest Coverage is ranked lower than
86% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 47.64 vs. BDX: 5.01 )
Ranked among companies with meaningful Interest Coverage only.
BDX' s Interest Coverage Range Over the Past 10 Years
Min: 2.89  Med: 15.87 Max: 42.29
Current: 5.01
2.89
42.29
Piotroski F-Score: 7
Altman Z-Score: 3.23
Beneish M-Score: -2.70
WACC vs ROIC
6.93%
10.00%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 15.17
BDX's Operating Margin % is ranked higher than
77% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.03 vs. BDX: 15.17 )
Ranked among companies with meaningful Operating Margin % only.
BDX' s Operating Margin % Range Over the Past 10 Years
Min: 10.45  Med: 19.61 Max: 22.75
Current: 15.17
10.45
22.75
Net Margin % 10.67
BDX's Net Margin % is ranked higher than
72% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.97 vs. BDX: 10.67 )
Ranked among companies with meaningful Net Margin % only.
BDX' s Net Margin % Range Over the Past 10 Years
Min: 6.76  Med: 15.56 Max: 18.49
Current: 10.67
6.76
18.49
ROE % 16.90
BDX's ROE % is ranked higher than
82% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. BDX: 16.90 )
Ranked among companies with meaningful ROE % only.
BDX' s ROE % Range Over the Past 10 Years
Min: 11.38  Med: 24.34 Max: 28.17
Current: 16.9
11.38
28.17
ROA % 5.20
BDX's ROA % is ranked higher than
59% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. BDX: 5.20 )
Ranked among companies with meaningful ROA % only.
BDX' s ROA % Range Over the Past 10 Years
Min: 3.57  Med: 11.79 Max: 14.79
Current: 5.2
3.57
14.79
ROC (Joel Greenblatt) % 35.33
BDX's ROC (Joel Greenblatt) % is ranked higher than
81% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.60 vs. BDX: 35.33 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
BDX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 21.71  Med: 35.48 Max: 40.37
Current: 35.33
21.71
40.37
3-Year Revenue Growth Rate 12.40
BDX's 3-Year Revenue Growth Rate is ranked higher than
80% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.80 vs. BDX: 12.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
BDX' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.4  Med: 8.4 Max: 12.4
Current: 12.4
4.4
12.4
3-Year EBITDA Growth Rate 8.50
BDX's 3-Year EBITDA Growth Rate is ranked higher than
59% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. BDX: 8.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
BDX' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -11  Med: 8.5 Max: 32.2
Current: 8.5
-11
32.2
3-Year EPS without NRI Growth Rate -1.30
BDX's 3-Year EPS without NRI Growth Rate is ranked lower than
53% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. BDX: -1.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
BDX' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -14.2  Med: 10.6 Max: 21.9
Current: -1.3
-14.2
21.9
GuruFocus has detected 8 Warning Signs with Becton, Dickinson and Co $BDX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» BDX's 30-Y Financials

Financials (Next Earnings Date: 2017-08-04 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Becton, Dickinson and Co

SymbolPriceYieldDescription
BDXA54.630.00

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NYSE:BAX, OTCPK:ESLOY, NAS:ILMN, NYSE:BCR, OTCPK:CLPBY, NYSE:MTD, NYSE:WAT, OTCPK:TRUMF, NAS:XRAY, NAS:HOLX, OTCPK:OCPNY, NYSE:COO, NYSE:RMD, OTCPK:SAUHY, NYSE:WST, NYSE:STE, NYSE:HRC, OTCPK:GNGBF, NAS:ICUI, NYSE:CMD » details
Traded in other countries:BOX.Germany, BDX.Switzerland, 0R19.UK,
Headquarter Location:USA
Becton, Dickinson and Co is a medical technology company, engaged in the manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, general public and clinical laboratories.

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. International revenue accounts for 60% of the company's business. With CareFusion, BD has entered into medical systems (such as infusion pumps, ventilators, and respirators), as well as procedural solutions businesses.

Ratios

vs
industry
vs
history
PE Ratio 32.31
BDX's PE Ratio is ranked lower than
56% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.49 vs. BDX: 32.31 )
Ranked among companies with meaningful PE Ratio only.
BDX' s PE Ratio Range Over the Past 10 Years
Min: 10.27  Med: 19.46 Max: 47.83
Current: 32.31
10.27
47.83
Forward PE Ratio 18.80
BDX's Forward PE Ratio is ranked higher than
87% of the 39 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.62 vs. BDX: 18.80 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 32.31
BDX's PE Ratio without NRI is ranked lower than
55% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.49 vs. BDX: 32.31 )
Ranked among companies with meaningful PE Ratio without NRI only.
BDX' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.02  Med: 20.98 Max: 47.83
Current: 32.31
13.02
47.83
Price-to-Owner-Earnings 27.18
BDX's Price-to-Owner-Earnings is ranked higher than
61% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 33.25 vs. BDX: 27.18 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
BDX' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.59  Med: 17.91 Max: 38.44
Current: 27.18
10.59
38.44
PB Ratio 5.23
BDX's PB Ratio is ranked lower than
69% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.28 vs. BDX: 5.23 )
Ranked among companies with meaningful PB Ratio only.
BDX' s PB Ratio Range Over the Past 10 Years
Min: 2.96  Med: 4.11 Max: 5.6
Current: 5.23
2.96
5.6
PS Ratio 3.45
BDX's PS Ratio is ranked lower than
52% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. BDX: 3.45 )
Ranked among companies with meaningful PS Ratio only.
BDX' s PS Ratio Range Over the Past 10 Years
Min: 1.99  Med: 2.75 Max: 3.54
Current: 3.45
1.99
3.54
Price-to-Free-Cash-Flow 23.02
BDX's Price-to-Free-Cash-Flow is ranked higher than
68% of the 71 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.86 vs. BDX: 23.02 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
BDX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.39  Med: 19.87 Max: 35.09
Current: 23.02
13.39
35.09
Price-to-Operating-Cash-Flow 16.49
BDX's Price-to-Operating-Cash-Flow is ranked higher than
68% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.73 vs. BDX: 16.49 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
BDX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.75  Med: 12.45 Max: 19.44
Current: 16.49
8.75
19.44
EV-to-EBIT 28.94
BDX's EV-to-EBIT is ranked lower than
60% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.50 vs. BDX: 28.94 )
Ranked among companies with meaningful EV-to-EBIT only.
BDX' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.7  Med: 14.85 Max: 40.4
Current: 28.94
9.7
40.4
EV-to-EBITDA 18.37
BDX's EV-to-EBITDA is ranked higher than
52% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.46 vs. BDX: 18.37 )
Ranked among companies with meaningful EV-to-EBITDA only.
BDX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.5  Med: 11.2 Max: 22.6
Current: 18.37
7.5
22.6
PEG Ratio 10.77
BDX's PEG Ratio is ranked lower than
91% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.81 vs. BDX: 10.77 )
Ranked among companies with meaningful PEG Ratio only.
BDX' s PEG Ratio Range Over the Past 10 Years
Min: 0.92  Med: 1.81 Max: 27.81
Current: 10.77
0.92
27.81
Shiller PE Ratio 34.25
BDX's Shiller PE Ratio is ranked higher than
69% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.38 vs. BDX: 34.25 )
Ranked among companies with meaningful Shiller PE Ratio only.
BDX' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.15  Med: 24.94 Max: 40
Current: 34.25
17.15
40
Current Ratio 1.22
BDX's Current Ratio is ranked lower than
82% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. BDX: 1.22 )
Ranked among companies with meaningful Current Ratio only.
BDX' s Current Ratio Range Over the Past 10 Years
Min: 1.14  Med: 1.91 Max: 5.82
Current: 1.22
1.14
5.82
Quick Ratio 0.78
BDX's Quick Ratio is ranked lower than
85% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.73 vs. BDX: 0.78 )
Ranked among companies with meaningful Quick Ratio only.
BDX' s Quick Ratio Range Over the Past 10 Years
Min: 0.7  Med: 1.22 Max: 5.1
Current: 0.78
0.7
5.1
Days Inventory 101.82
BDX's Days Inventory is ranked higher than
68% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.19 vs. BDX: 101.82 )
Ranked among companies with meaningful Days Inventory only.
BDX' s Days Inventory Range Over the Past 10 Years
Min: 101.82  Med: 120.58 Max: 127.55
Current: 101.82
101.82
127.55
Days Sales Outstanding 46.48
BDX's Days Sales Outstanding is ranked higher than
74% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.12 vs. BDX: 46.48 )
Ranked among companies with meaningful Days Sales Outstanding only.
BDX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.48  Med: 58.29 Max: 62.16
Current: 46.48
46.48
62.16

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.46
BDX's Dividend Yield % is ranked higher than
70% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.17 vs. BDX: 1.46 )
Ranked among companies with meaningful Dividend Yield % only.
BDX' s Dividend Yield % Range Over the Past 10 Years
Min: 1.12  Med: 1.77 Max: 2.44
Current: 1.46
1.12
2.44
Dividend Payout Ratio 0.46
BDX's Dividend Payout Ratio is ranked lower than
74% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. BDX: 0.46 )
Ranked among companies with meaningful Dividend Payout Ratio only.
BDX' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.33 Max: 0.72
Current: 0.46
0.26
0.72
3-Year Dividend Growth Rate 10.10
BDX's 3-Year Dividend Growth Rate is ranked higher than
56% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.40 vs. BDX: 10.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
BDX' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 2.6  Med: 11.7 Max: 29.1
Current: 10.1
2.6
29.1
Forward Dividend Yield % 1.50
BDX's Forward Dividend Yield % is ranked higher than
63% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.27 vs. BDX: 1.50 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.35
BDX's 5-Year Yield-on-Cost % is ranked higher than
69% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. BDX: 2.35 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
BDX' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.8  Med: 2.85 Max: 3.93
Current: 2.35
1.8
3.93
3-Year Average Share Buyback Ratio -3.20
BDX's 3-Year Average Share Buyback Ratio is ranked higher than
55% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.20 vs. BDX: -3.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
BDX' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.2  Med: 1.3 Max: 6.1
Current: -3.2
-3.2
6.1

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.91
BDX's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
63% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.24 vs. BDX: 1.91 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
BDX' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.99  Med: 1.59 Max: 3.81
Current: 1.91
0.99
3.81
Price-to-Intrinsic-Value-DCF (Earnings Based) 3.02
BDX's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
59% of the 22 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.12 vs. BDX: 3.02 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.26
BDX's Price-to-Median-PS-Value is ranked lower than
57% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. BDX: 1.26 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
BDX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.4  Med: 0.85 Max: 1.29
Current: 1.26
0.4
1.29
Earnings Yield (Greenblatt) % 3.46
BDX's Earnings Yield (Greenblatt) % is ranked higher than
63% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. BDX: 3.46 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
BDX' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.5  Med: 6.75 Max: 10.4
Current: 3.46
2.5
10.4
Forward Rate of Return (Yacktman) % 8.17
BDX's Forward Rate of Return (Yacktman) % is ranked lower than
54% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.07 vs. BDX: 8.17 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
BDX' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 5  Med: 14.4 Max: 19.6
Current: 8.17
5
19.6

More Statistics

Revenue (TTM) (Mil) $12,320.00
EPS (TTM) $ 6.04
Beta0.98
Short Percentage of Float5.52%
52-Week Range $161.29 - 195.88
Shares Outstanding (Mil)227.35

Analyst Estimate

Sep17 Sep18 Sep19
Revenue (Mil $) 12,087 13,691 13,164
EPS ($) 9.41 10.34 11.32
EPS without NRI ($) 9.41 10.34 11.32
EPS Growth Rate
(Future 3Y To 5Y Estimate)
9.78%
Dividends per Share ($) 2.94 3.19 3.69
» More Articles for BDX

Headlines

Articles On GuruFocus.com
Boeing Takes Lead Over Airbus With $30 Billion Worth of Orders on Day 1 of Paris Air Show Jun 25 2017 
Berkshire Hathaway’s Recent Investment: Home Capital Group Jun 25 2017 
Stocks That Fell to 3-Year Lows in the Week of June 23 Jun 24 2017 
Weekly Top Insider Buys Highlight for the Week of June 23 Jun 24 2017 
ID Watchdog Announces Special and Annual General Meeting Date and Record Date Jun 23 2017 
Ironclad Performance Wear Postpones 2017 Annual Meeting of Stockholders Jun 23 2017 
Delta and Korean Air Create Leading trans-Pacific Joint Venture Jun 23 2017 
Harwood Feffer LLP Announces Investigation of EnerNOC, Inc. Jun 23 2017 
Charles D. Christy Named Chief Financial Officer Jun 23 2017 
Harwood Feffer LLP Announces Investigation of CardConnect Corp. Jun 23 2017 

More From Other Websites
Corporate News Blog - BD Receives FDA 501(k) Clearance for Snowden-Pencer 3.00 mm Laparoscopic... Jun 22 2017
ETFs with exposure to Becton, Dickinson & Co. : June 20, 2017 Jun 20 2017
Today's iQ100 leaders Jun 20 2017
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments Jun 20 2017
Becton, Dickinson & Co. :BDX-US: Earnings Analysis: Q2, 2017 By the Numbers : June 19, 2017 Jun 19 2017
Steven Cohen Bullish on Health Care Sector Jun 14 2017
Becton (BDX) with FlowJo to Provide Cloud Platform Services Jun 14 2017
FlowJo and BD to Provide Cloud Platform for Real-Time Single-Cell Marketing Collaboration Jun 13 2017
Kaon Interactive Wins Three Awards at DxMA Global Marketing Summit Jun 12 2017
BD and Bard Receive Second Requests from FTC under HSR Act Jun 09 2017
FDA Approval Boosts Baxter’s Generic Injectable Business Jun 09 2017
Becton, Dickinson & Co. : BDX-US: Dividend Analysis : June 09th, 2017 (record date) : By the numbers... Jun 08 2017
BD Receives FDA 510(K) Clearance for Molecular Test for Harmful Intestinal Bacteria Causing... Jun 05 2017
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes Jun 05 2017
Why Is Becton, Dickinson (BDX) Up 3% Since the Last Earnings Report? Jun 02 2017
Nine members of iQ100 hit all time highs Jun 01 2017
Becton, Dickinson at 52-Week High: What's Driving the Stock? May 31 2017
New Issue Corporate Bond Market Springs to Life Before Summer Slowdown May 30 2017
BD on the Street: The Latest Analyst Recommendations May 24 2017
BD Board Declares Dividend May 23 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}